Day: September 3, 2020

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that the Company will present at two upcoming virtual investor conferences.Wells Fargo 2020 Virtual Healthcare ConferenceDate: Thursday, September 10Time: 2:00 PM Eastern TimeOppenheimer Fall Healthcare Life Sciences & MedTech SummitDate: Tuesday, September 21Time: 4:10 PM Eastern TimeLive webcasts of the events will be available on the Sunesis website at http://ir.sunesis.com. A replay of each will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks.About Sunesis PharmaceuticalsSunesis is a biopharmaceutical company developing novel targeted inhibitors for the treatment of hematologic and solid cancers. Sunesis has built an experienced...

CRANBURY, N.J., Sept. 03, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in upcoming presentations at the following virtual investor conferences in September:Citi’s 15th Annual BioPharma Virtual Conference on Thursday, September 10, 2020 at 8:55 a.m. E.T.Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020 at 10:00 a.m. E.T.Bank of America Global Healthcare Conference on Friday, September 18, 2020 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)A live audio webcast of each presentation can be accessed via the Investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.About Amicus TherapeuticsAmicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology...

Publication demonstrates genome sequencing as the optimal standard for genetic testingStudy presents the largest cohort of its kind with over 1,000 index casesGenome sequencing minimizes stepwise testing, thereby accelerating diagnosis for rare disease patientsCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 03, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage diagnostics and genetic research company, today announced that its scientific publication ‘Successful application of genome sequencing in a diagnostic setting: 1,007 index cases from a clinically heterogeneous cohort’ has appeared in the European Journal of Human Genetics (The official journal of the European Society of Human Genetics) (https://www.nature.com/articles/s41431-020-00713-9) – one of the world’s leading medical genetic...

First significant exploration undertaken on Judd by K92, with approximately 109 metres of 5.5m x 5.5m development completed on Judd #1 Vein, one of four known Judd veins. Based on grade control channel sampling, an estimated 6,200 tonnes at 5.5 g/t gold equivalent (“AuEq”) or 3.6 g/t gold, 1.11% copper and 19 g/t silver with an average thickness of 3.4 metres was extracted from Judd #1 Vein. Development drive reported solid geotechnical competency and multiple high-grade Judd #1 Vein faces from channel sampling, including:• 2.2m thickness at 18.7 g/t AuEq or 17.4 g/t Au, 0.65% Cu and 26 g/t Ag;• 3.5m thickness at 9.8 g/t AuEq or 3.7 g/t Au, 3.73% Cu and 42 g/t Ag;• 3.7m thickness at 9.5 g/t AuEq or 7.4 g/t Au, 1.28% Cu and 17 g/t Ag, and;• 4.2m thickness at 8.7 g/t AuEq or 6.0 g/t Au, 1.46% Cu and 37 g/t Ag.Mineralization style from development...

BOSTON and MANCHESTER, N.H., Sept. 03, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG), the New Hampshire Lottery and South Side Tavern today announced the opening of DraftKings Sportsbook at Manchester. The second retail sportsbook location to open in the state, DraftKings Sportsbook at Manchester, located at 1279 South Willow St. in Manchester, will offer bettors a unique gaming experience at a location that has been voted a top bar and restaurant in the state for three years straight, appearing in the Best of NH Awards category by New Hampshire Magazine.Located within South Side Tavern’s sports bar, DraftKings Sportsbook at Manchester has ample betting kiosks, wall-to-wall TVs, and seating for groups large and small. The 40,000-square-foot property located just off Exit 1 on Interstate 293 is a longtime charitable gaming...

TEL AVIV, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces the award for Best ESC Congress Poster for the presentation of updated data from the large, long-term PARADIGM-EXTEND study of the CGuard™ Embolic Prevention System (EPS), as part of the European Society of Cardiology 2020 Carotid Update e-presentation at the European Society of Cardiology (ESC) Congress 2020. PARADIGM/EXTEND is an investigator-driven on-going study performed with CGuard Carotid stent for primary and secondary stroke prevention in a large, consecutive all-comers population, with 5 years (60 months) follow-up.PARADIGM-EXTEND current results for 480 patients of the expected total of...

TORONTO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Wallbridge Mining Company Limited (TSX:WM) (“Wallbridge” or the “Company”) today reports that it has completed the first phase of metallurgical testing of the Tabasco and Area 51 zones from Wallbridge’s Fenelon Gold Project (“Fenelon”) at SGS Laboratories (“SGS”), achieving gold recoveries up to 99.1% using conventional and proven technologies.The goals of this latest round of metallurgical testing by SGS were to evaluate gold recovery for various grind sizes and processing technologies for representative material from Tabasco and Area 51 zones.Representative samples from low-grade and high-grade areas of the Tabasco (Figure 1) and Area 51 (Figure 2) zones were tested for their amenability to gravity separation as well as cyanidation under varying grind sizes and conditions (Table 1). Testing...

BEIJING, Sept. 03, 2020 (GLOBE NEWSWIRE) — Secoo Holding Limited (“Secoo”, the “Company” or “We”) (NASDAQ: SECO), Asia’s leading online integrated upscale products and services platform, today announced its unaudited financial results for the second quarter ended June 30, 2020.Highlights for Second Quarter 2020:GMV1 reached RMB3,632.0 million (US$514.1 million) for Q2 2020, representing an increase of 12.1% from RMB3,238.8 million for Q2 2019.Total number of orders2 was 1,028.0 thousand for Q2 2020, representing an increase of 7.7% from 954.8 thousand for Q2 2019.Number of active customers3 increased by 9.2% to 467.7 thousand for Q2 2020 from 428.4 thousand for Q2 2019.Total revenues was RMB1,306.3 million (US$184.9 million) for Q2 2020, compared with RMB1,712.1 million for Q2 2019.Net income was RMB5.9 million (US$0.8 million)...

Los Angeles, CA, Sept. 03, 2020 (GLOBE NEWSWIRE) — Los Angeles, CA, September 3, 2020 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC., (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a revenue-generating, product development, and production company that has significantly changed the way air is moved, filtered and sterilized, today announced it has entered into a pilot distribution agreement with SteriLED, a division of Principal Lighting Group, LLC. (SteriLED). SteriLED has agreed to supply Kronos with its commercial-grade ultraviolet germicidal irradiation product line that was laboratory tested to effectively disinfect objects and surfaces without the need for consumable cleaning agents. These products utilize proprietary and state-of-the-art UVC semiconductor diodes to output a high-power, 275nm...